W Advisors LLC Buys Shares of 7,622 CVS Health Co. (NYSE:CVS)

W Advisors LLC purchased a new position in shares of CVS Health Co. (NYSE:CVSFree Report) in the 2nd quarter, Holdings Channel reports. The firm purchased 7,622 shares of the pharmacy operator’s stock, valued at approximately $450,000.

Several other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC increased its position in CVS Health by 11.4% in the 4th quarter. International Assets Investment Management LLC now owns 16,744 shares of the pharmacy operator’s stock valued at $1,322,000 after acquiring an additional 1,715 shares during the period. Gryphon Financial Partners LLC raised its position in CVS Health by 48.3% during the 4th quarter. Gryphon Financial Partners LLC now owns 8,151 shares of the pharmacy operator’s stock worth $654,000 after purchasing an additional 2,653 shares during the last quarter. Northwest Financial Advisors bought a new stake in shares of CVS Health in the 4th quarter valued at about $42,000. AGF Management Ltd. increased its stake in shares of CVS Health by 34.6% in the fourth quarter. AGF Management Ltd. now owns 341,619 shares of the pharmacy operator’s stock valued at $26,974,000 after buying an additional 87,766 shares during the period. Finally, Jump Financial LLC raised its position in shares of CVS Health by 27.9% during the fourth quarter. Jump Financial LLC now owns 40,900 shares of the pharmacy operator’s stock worth $3,229,000 after acquiring an additional 8,928 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

CVS has been the subject of a number of recent analyst reports. Baird R W raised shares of CVS Health to a “hold” rating in a research report on Thursday, May 30th. Barclays lowered their target price on shares of CVS Health from $65.00 to $63.00 and set an “equal weight” rating for the company in a research note on Thursday, August 8th. JPMorgan Chase & Co. cut their price target on shares of CVS Health from $101.00 to $86.00 and set an “overweight” rating on the stock in a research report on Thursday, May 30th. Deutsche Bank Aktiengesellschaft lowered their price objective on CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Evercore ISI decreased their target price on CVS Health from $65.00 to $62.00 and set an “outperform” rating for the company in a research note on Thursday, August 8th. Eleven research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $72.48.

View Our Latest Report on CVS Health

CVS Health Trading Down 0.6 %

NYSE CVS opened at $57.75 on Friday. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $72.50 billion, a P/E ratio of 10.15, a PEG ratio of 0.80 and a beta of 0.53. The business has a fifty day simple moving average of $58.29 and a 200 day simple moving average of $63.78. CVS Health Co. has a 12 month low of $52.77 and a 12 month high of $83.25.

CVS Health (NYSE:CVSGet Free Report) last released its quarterly earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 earnings per share for the quarter, beating analysts’ consensus estimates of $1.73 by $0.10. CVS Health had a net margin of 1.98% and a return on equity of 12.72%. The company had revenue of $91.23 billion for the quarter, compared to analyst estimates of $91.41 billion. During the same period last year, the firm earned $2.21 earnings per share. The firm’s revenue was up 2.6% on a year-over-year basis. On average, analysts predict that CVS Health Co. will post 6.52 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 1st. Investors of record on Monday, July 22nd were given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.61%. The ex-dividend date was Monday, July 22nd. CVS Health’s payout ratio is 46.75%.

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Co. (NYSE:CVSFree Report).

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.